Abstract
We recently showed that p300/CREB-binding protein (CBP) plays an important role in maintaining cells in G0/G1 phase by keeping c-myc in a repressed state. Consistent with this, adenovirus E1A oncoprotein induces c-myc in a p300-dependent manner, and the c-myc induction is linked to S-phase induction. The induction of S phase by E1A is dependent on its binding to and inactivating several host proteins including p300/CBP. To determine whether there is a correlation between the host proteins binding to the N-terminal region of E1A, activation of c-myc and induction of S phase, we assayed the c-myc and S-phase induction in quiescent human cells by infecting them with Ad N-terminal E1A mutants with mutations that specifically affect binding to different chromatin-associated proteins including pRb, p300, p400 and p300/CBP-associated factor (PCAF). We show that the mutants that failed to bind to p300 or pRb were severely defective for c-myc and S-phase induction. The induction of c-myc and S phase was only moderately affected when E1A failed to bind to p400. Furthermore, analysis of the E1A mutants that fail to bind to p300, and both p300 and PCAF suggests that PCAF may also play a role in c-myc repression, and that the two chromatin-associated proteins may repress c-myc independently. In summary, these results suggest that c-myc deregulation by E1A through its interaction with these chromatin-associated proteins is an important step in the E1A-mediated cell cycle deregulation and possibly in cell transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Baluchamy S, Rajabi HN, Thimmapaya R, Navaraj A, Thimmapaya B . (2003). Repression of c-myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity. Proc Natl Acad Sci USA 100: 9524–9529.
Barbeau D, Charbonneau R, Whalen SG, Bayley ST, Branton PE . (1994). Functional interactions within adenovirus E1A protein complexes. Oncogene 9: 359–373.
Buchmann AM, Swaminathan S, Thimmapaya B . (1998). Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein. Mol Cell Biol 18: 4565–4576.
Chen C, Kang Y, Siegel PM, Massague J . (2002). E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110: 19–32.
Doyon Y, Selleck W, Lane WS, Tan S, Cote J . (2004). Structural and functional conservation of the NuA4 histone acetyl transferase complex from yeast to humans. Mol Cell Biol 24: 1884–1896.
Egan C, Jelsma TN, Howe JA, Bayley ST, Ferguson B, Branton PE . (1988). Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. J Virol 8: 3955–3959.
Frisch SM, Mymryk JS . (2002). Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 6: 441–4452.
Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V et al. (2001). The p400 target is an essential E1A transformation target. Cell 106: 297–307.
Goodman RH, Smolik S . (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev 14: 1553–1577.
Harbour JW . (2001). Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 119: 1699–1704.
Kolli S, Buchmann AM, Williams J, Thimmapaya B . (2001). Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-myc. Proc Natl Acad Sci USA 98: 4646–4651.
Lang SE, Hearing P . (2003). The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene 22: 2836–2841.
Mitchell KO, El-Deiry WS . (1999). Overexpression of c-myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ 10: 223–230.
Moran E . (1993). Interaction of adenoviral proteins with pRB and p53. FASEB J 7: 880–885.
Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E et al. (2000). Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res 60: 4289–4298.
Puri PL, Sartorelli V, Yang X, Hammamor Y, Ogryzko V, Howard B et al. (1997). Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1: 35–45.
Rajabi HN, Baluchamy S, Kolli S, Nag A, Srinivas R, Raychaudhari P et al. (2005). Effects of depletion of CREB-binding protein on c-myc regulation and cell cycle G1–S transition. J Biol Chem 280: 361–374.
Reid JL, Bannister AJ, Zegerman P, Martinez-Balbas MA, Kouzarides T . (1998). E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J 17: 4469–4477.
Santoso B, Kadonaga JT . (2006). Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300. Nat Struct Mol Biol 2: 131–139.
Soule HD, Maloney TN, Wolman SR, Peterson WDJ, Brenz R, McGrath C et al. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line MCF-10. Cancer Res 50: 6075–6086.
Sterner DE, Berger SL . (2000). Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435–459.
Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, Chan HM et al. (2004). E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G(1). Mol Cell Biol 24: 4546–4556.
Wang H, Moran E, Yaciuk P . (1995). E1A promotes association of p300 and pRB in multimeric complexes required for normal biological activity. J Virol 69: 7917–7924.
Wang HG, Rikitake Y, Carter MC, Yaciuk P, Abraham SE, Zerler B et al. (1993). Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol 67: 476–488.
Acknowledgements
This work was supported by the PHS grant CA74403. We are grateful to S Bayely (U McMaster, Canada) for providing certain adenovirus mutants, and W El-Deiry (U Pennsylvania) for providing Adc-myc. We sincerely apologize that because of space limitations, we could not include all the relevant references in this report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baluchamy, S., Sankar, N., Navaraj, A. et al. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction. Oncogene 26, 781–787 (2007). https://doi.org/10.1038/sj.onc.1209825
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1209825
Keywords
This article is cited by
-
Predictive genetic markers of coagulation, inflammation and apoptosis in Perthes disease—Serbian experience
European Journal of Pediatrics (2015)
-
Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype
Molecular Cancer (2009)
-
p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc
Oncogene (2008)


